Fourteen publishing entities behind USA Today and 18 regional newspapers allege that OpenAI copied hundreds of thousands of articles for AI training and produced outputs that can substitute for their reporting. The claims have not been decided.
A peer-reviewed design raises numerical aperture to at least 0.75 while retaining the current EUV light source. ASML has started development, but has not committed to building a commercial machine.
A Dutch court found that Merck's subcutaneous Keytruda infringes Halozyme's EP622 drug-delivery patent. The order does not cover intravenous Keytruda, and Merck says the patent is invalid and it is evaluating its next steps.
Upscale has introduced a stack combining its own switch silicon, Nvidia Spectrum-X systems and orchestration software. General availability is planned for early 2027, and the performance claims still need independent validation.
The agreement ends identified pending litigation and licenses Netlist's worldwide portfolio, including server-DIMM and high-bandwidth-memory patents. The $600 million will be paid quarterly, not as a lump sum.
The multi-year agreement covers 5G, computing, AI and networking portfolios and includes Qualcomm’s purchase of selected Huawei U.S. patents. Financial terms, portfolio lists and royalty mechanics remain undisclosed.
A Delaware jury will hear Qualcomm’s claims that Arm withheld contractually required tools and publicized a termination threat. Arm denies wrongdoing, and the court has not decided whether Qualcomm can suspend royalties for up to five years.
Novartis will pay $575 million upfront for worldwide rights to ABO2203 and options on other Abogen RNA programs. The much larger headline figure depends on development, approvals and commercialization that may never occur.
A prospective convertible facility disclosed in Anthropic’s IPO papers shows how AI infrastructure is becoming a financing structure as well as a technology stack. The $42 billion is a ceiling, not money already borrowed or spent.